Pembrolizumab Enhances the Anti-Leukemia Activity of Antigen Specific Cytotoxic T Lymphocytes

Authors

Zara Italia, The University of Texas MD Anderson Cancer CenterFollow
Kathleen Ready, The University of Texas MD Anderson Cancer CenterFollow
Mao Zhang, The University of Texas MD Anderson Cancer Center
Maria R. Khouri, The University of Texas MD Anderson Cancer Center
Pariya Sukhumalchandra, The University of Texas MD Anderson Cancer Center
Anne V. Phillips, The University of Texas MD Anderson Cancer Center
Na Qiao, The University of Texas MD Anderson Cancer Center
Celine Kerros, The University of Texas MD Anderson Cancer Center
Lisa St. John, The University of Texas MD Anderson Cancer Center
Alexander A. Perakis, The University of Texas MD Anderson Cancer Center
Daniel Ghaisariee, The University of Texas MD Anderson Cancer Center
Karen Clise-Dwyer, The University of Texas MD Anderson Cancer Center
Elizabeth Mittendorf, Dana-Farber/Brigham and Women’s Cancer Center
Naval G. Daver, The University of Texas MD Anderson Cancer Center
Jeffrey J. Molldrem, The University of Texas MD Anderson Cancer CenterFollow
Qing Ma, The University of Texas MD Anderson Cancer Center
Gheath Alatrash, The University of Texas MD Anderson Cancer Center

Files

Program Affiliation

UPWARDS Summer Program

Keywords

Acute Myeloid Leukemia, Pembrolizumab, Cytotoxic T Lymphocytes, PR1 Antigen Specific CTL, CG1 Antigen Specific CTL

Recommended Citation

Italia, Zara; Ready, Kathleen; Zhang, Mao; Khouri, Maria R.; Sukhumalchandra, Pariya; Phillips, Anne V.; Qiao, Na; Kerros, Celine; St. John, Lisa; Perakis, Alexander A.; Ghaisariee, Daniel; Clise-Dwyer, Karen; Mittendorf, Elizabeth; Daver, Naval G.; Molldrem, Jeffrey J.; Ma, Qing; and Alatrash, Gheath, "Pembrolizumab Enhances the Anti-Leukemia Activity of Antigen Specific Cytotoxic T Lymphocytes" (2023). Summer Experience 2023. 69.
https://openworks.mdanderson.org/sumexp23/69